Becton, Dickinson and Co (BDX)
225.40
-4.37 -1.90%
NYSE
Apr 1, 20:00
Delayed 2m
USD
View All Key Stats
Key Stats
| Income Statement | |
| Revenue (TTM) | 17.35B |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | 2.72 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | 911.00M |
| Profitability | |
| Gross Profit Margin (Quarterly) | 46.82% |
| Profit Margin (Quarterly) | 6.58% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield | 1.38% |
| Price and Valuation | |
| Market Cap | 61.12B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio | 3.555 |
| PE Ratio | 82.87 |
| Price to Book Value | 2.883 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio | 0.9153 |
| Free Cash Flow (Quarterly) | 541.00M |
| Return on Equity | Upgrade |
View All BDX News
News
-
WireHeadlineTime (ET)
-
Globe Newswire04/01 22:50
-
Yahoo04/01 17:45
-
Globe Newswire04/01 15:00
-
Yahoo04/01 14:25
-
Yahoo04/01 13:31
-
Yahoo04/01 10:45
-
Yahoo04/01 10:43
-
Yahoo04/01 09:51
-
MT Newswires04/01 07:40
-
Globe Newswire03/31 22:50
View All Events
Events
| Date | Type | Description |
|---|---|---|
| 05/08/2020 08:00 EDT | Misc | Becton, Dickinson and Co Second Quarter Earnings Conference Call in 2020 |
| 05/08/2020 | Earnings | Becton, Dickinson and Co Second Quarter Earnings in 2020 Release |
| 03/09/2020 | Dividends | Amount: 0.79, Declared Date: Jan 27 2020, Pay Date: Mar 31 2020 |
| 02/06/2020 08:00 EST | Misc | Becton, Dickinson and Co First Quarter Earnings Conference Call for 2020 |
| 02/06/2020 | Earnings | Becton, Dickinson and Co First Quarter Earnings in 2020 Release |
| 01/28/2020 | Misc | Becton, Dickinson and Co Annual General Meeting for 2019 |
| 12/09/2019 | Dividends | Amount: 0.79, Declared Date: Nov 25 2019, Pay Date: Dec 31 2019 |
| 11/27/2019 | Misc | Becton, Dickinson and Co Annual Report for 2019 |
| 11/05/2019 08:00 EST | Misc | Becton, Dickinson and Co Fourth Quarter Earnings Conference Call for 2019 |
| 11/05/2019 | Earnings | Becton, Dickinson and Co Fourth Quarter Earnings in 2019 Release |
Fundamentals
Income Statement View Statement
Ratings & Reports
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
- One Page Report Download
Advertisement
Edit
Profile
- URL: http://www.bd.com
- Investor Relations URL: http://www.bd.com/investors/
- HQ State/Province: New Jersey
- Sector: Healthcare
- Industry: Medical Instruments & Supplies
- Equity Style: Large Cap/Blend
- Next Earnings Release: May. 08, 2020
- Last Earnings Release: Feb. 06, 2020
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: Mar. 09, 2020
- Description: Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.
Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 225.40 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Top Fund Holders
| Symbol | Name | Weighting |
|---|---|---|
| FSMEX | Fidelity® Select Medical Tech and Devcs | 10.14% |
| THISX | T. Rowe Price Health Sciences I | 4.45% |
| IHI | iShares US Medical Devices ETF | 3.89% |
| FRDRX | Franklin Rising Dividends R | 3.31% |
| PACLX | T. Rowe Price Capital Appreciation Adv | 2.47% |
| IGAF.TO | IA Clarington Global Allocation ETF | 2.04% |
| XLV | Health Care Select Sector SPDR® ETF | 1.82% |
| IYH | iShares US Healthcare ETF | 1.67% |
| VHT | Vanguard Health Care ETF | 1.58% |
| RRBGX | T. Rowe Price Blue Chip Growth R | 1.38% |
| RRGSX | T. Rowe Price Growth Stock R | 1.25% |
| IXJ | iShares Global Healthcare ETF | 1.22% |
Other Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- BDX Tweets Stocktwits
Advertisement
